poisar

Stock

Genprex, Inc. GNPX

$7.43-8.04%

Overview

GNPX market data

Price History

GNPX price chart

Valuation & Profitability

Twelve Data
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$263.49
Diluted earnings per share over the trailing twelve months.
Beta
-0.86
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$0.42 – $55.00
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $5.4 · P/B 0.51.

Company news

8 captured
Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption TimesBenzinga · Jul 16, 2026, 12:55 PM
Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News PendingBenzinga · Jul 15, 2026, 11:50 PM
8-K filing — Genprex, Inc. (GNPX)SEC EDGAR · Jul 14, 2026, 1:23 PM
Genprex Receives Notice Of Allowance From CIPO For Patent Covering Use Of Reqorsa Gene Therapy In Combination With Either PD-1 Or PD-L1 Antibodies For Treatment Of Lung CancerBenzinga · Jun 22, 2026, 1:10 PM
Genprex Receives Nasdaq Noncompliance NoticeBenzinga · Jun 12, 2026, 9:10 PM
Genprex Files For Mixed Shelf Of Up To $250MBenzinga · Jun 5, 2026, 9:10 PM
Genprex Showcases Positive Preclinical Data On Its Diabetes Gene Therapy Drug Candidate At 2026 American Society Of Gene And Cell Therapy Annual MeetingBenzinga · May 14, 2026, 12:06 PM
Genprex Q1 EPS $(0.64) Up From $(13.00) YoYBenzinga · May 13, 2026, 9:36 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock